» Articles » PMID: 18708237

Interactions of Reverse Transcriptase Sequences in Pol with Gag and LysRS in the HIV-1 TRNALys3 Packaging/annealing Complex

Overview
Journal Virology
Specialty Microbiology
Date 2008 Aug 19
PMID 18708237
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

During HIV-1 assembly, tRNA(Lys3), the primer for reverse transcriptase (RT) in HIV-1, is selectively packaged into the virus due to a specific interaction between Gag and lysyl-tRNA synthetase (LysRS). However, while Gag alone will incorporate LysRS, tRNA(Lys3) packaging also requires the presence of RT thumb domain sequences in GagPol. The formation of a tRNA(Lys3) packaging/annealing complex involves an interaction between Gag/GagPol/viral RNA and LysRS/tRNA(Lys), and herein, we have investigated whether the transfer of tRNA(Lys3) from LysRS to RT sequences in Pol by a currently unknown mechanism is facilitated by an interaction between LysRS and Pol. We demonstrate that, in addition to its interaction with Gag, LysRS also interacts with sequences within the connection/RNaseH domains in RT. However, cytoplasmic Gag/Pol interactions, detected by either coimmunoprecipitation or incorporation of Pol into Gag viral-like particles, were found to be insensitive to the overexpression or underexpression of LysRS, indicating that a Gag/LysRS/RT interaction is not essential for Gag/Pol interactions. Based on this and previous work, including the observation that the RT connection domain is not required for tRNA(Lys3) packaging, but is required for tRNA(Lys3) annealing, a model is proposed for a tRNA(Lys3) packaging/annealing complex in which the interaction of Gag with Pol sequences during early viral assembly facilitates the retention in budding viruses of both tRNA(Lys3) and early Pol processing intermediates, with tRNA(Lys3) annealing to viral RNA further facilitated by the LysRS/RT interaction.

Citing Articles

Involvement of Human Cellular Proteins and Structures in Realization of the HIV Life Cycle: A Comprehensive Review, 2024.

Schemelev A, Davydenko V, Ostankova Y, Reingardt D, Serikova E, Zueva E Viruses. 2024; 16(11).

PMID: 39599797 PMC: 11599013. DOI: 10.3390/v16111682.


Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond.

Galindo-Feria A, Notarnicola A, Lundberg I, Horuluoglu B Front Immunol. 2022; 13:866087.

PMID: 35634293 PMC: 9136399. DOI: 10.3389/fimmu.2022.866087.


Advances in HIV-1 Assembly.

Lerner G, Weaver N, Anokhin B, Spearman P Viruses. 2022; 14(3).

PMID: 35336885 PMC: 8952333. DOI: 10.3390/v14030478.


Effect of Lysyl-tRNA Synthetase on the Maturation of HIV-1 Reverse Transcriptase.

Ilina T, Slack R, Guerrero M, Ishima R ACS Omega. 2020; 5(27):16619-16627.

PMID: 32685828 PMC: 7364630. DOI: 10.1021/acsomega.0c01449.


Plasma L-Carnitine and L-Lysine Concentrations in HIV-Infected Patients.

Butorov E Open Biochem J. 2018; 11:119-131.

PMID: 29387270 PMC: 5750727. DOI: 10.2174/1874091X01711010119.